Clearpoint Neuro Inc
NASDAQ:CLPT
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
4.46
13.46
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one CLPT stock under the Base Case scenario is 6.14 USD. Compared to the current market price of 12.74 USD, Clearpoint Neuro Inc is Overvalued by 52%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Clearpoint Neuro Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for CLPT cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Clearpoint Neuro Inc
Balance Sheet Decomposition
Clearpoint Neuro Inc
Current Assets | 46.6m |
Cash & Short-Term Investments | 32.8m |
Receivables | 3.5m |
Other Current Assets | 10.2m |
Non-Current Assets | 6m |
PP&E | 4.9m |
Intangibles | 758k |
Other Non-Current Assets | 385k |
Current Liabilities | 16.7m |
Accounts Payable | 822k |
Accrued Liabilities | 4.8m |
Other Current Liabilities | 11.1m |
Non-Current Liabilities | 3.7m |
Other Non-Current Liabilities | 3.7m |
Earnings Waterfall
Clearpoint Neuro Inc
Revenue
|
28.1m
USD
|
Cost of Revenue
|
-11.3m
USD
|
Gross Profit
|
16.8m
USD
|
Operating Expenses
|
-35.4m
USD
|
Operating Income
|
-18.6m
USD
|
Other Expenses
|
593k
USD
|
Net Income
|
-18m
USD
|
Free Cash Flow Analysis
Clearpoint Neuro Inc
USD | |
Free Cash Flow | USD |
ClearPoint Neuro reported a record revenue of $7.9 million for Q2 2024, marking a 32% increase from the previous year. This significant growth was driven by advancements across all four of their key pillars: biologics and drug delivery, neurosurgery navigation, therapy, and achieving global scale. Key highlights include a 148% increase in capital equipment and software revenue, a 47% reduction in operating cash burn, and a gross margin improvement to 63%. The company raised its full-year revenue guidance to a range of $30 to $33 million, forecasting a growth of 25% to 38% for the year.
What is Earnings Call?
CLPT Profitability Score
Profitability Due Diligence
Clearpoint Neuro Inc's profitability score is 30/100. The higher the profitability score, the more profitable the company is.
Score
Clearpoint Neuro Inc's profitability score is 30/100. The higher the profitability score, the more profitable the company is.
CLPT Solvency Score
Solvency Due Diligence
Clearpoint Neuro Inc's solvency score is 43/100. The higher the solvency score, the more solvent the company is.
Score
Clearpoint Neuro Inc's solvency score is 43/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CLPT Price Targets Summary
Clearpoint Neuro Inc
According to Wall Street analysts, the average 1-year price target for CLPT is 12.07 USD with a low forecast of 10.1 USD and a high forecast of 15.75 USD.
Dividends
Current shareholder yield for CLPT is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
CLPT Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Clearpoint Neuro, Inc. engages in the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain and heart. The company is headquartered in Solana Beach, California and currently employs 80 full-time employees. The company went IPO on 2019-07-03. The Company’s product platforms include SmartFlow Cannula and ClearPoint Navigation System Software. The SmartFlow Cannula is being utilized in approved combination product clinical and preclinical studies by pharmaceutical companies and academic research customers for various research and clinical trials in connection with delivery of therapeutic agents. The ClearPoint Navigation System Software is a software for surgical planning, navigation to target, and device delivery. The Company’s software and MRI-compatible workstation coordinate with the scanner to effectively utilize intraprocedural MR images. This provides real-time navigational instruction for the neurosurgeon to reach the desired anatomical target with a high degree of precision.
Contact
IPO
Employees
Officers
The intrinsic value of one CLPT stock under the Base Case scenario is 6.14 USD.
Compared to the current market price of 12.74 USD, Clearpoint Neuro Inc is Overvalued by 52%.